A Randomized, Double-blinded, Active Controlled Crossover Clinical Trial to Investigate PK, PD and Safety of GBPD002
Condition(s):Natural Blood and Blood Product ToxicityLast Updated:October 20, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Natural Blood and Blood Product ToxicityLast Updated:October 20, 2022Completed
Condition(s):Hemolytic-Uremic Syndrome; AnemiaLast Updated:January 13, 2021Completed
Condition(s):Anemia; Endometrial DiseasesLast Updated:January 23, 2018Completed
Condition(s):Oral Lichen PlanusLast Updated:February 1, 2024Not yet recruiting
Condition(s):Erythropoietin; RecessionLast Updated:January 13, 2023Recruiting
Condition(s):Perinatal HypoxiaLast Updated:August 30, 2021Completed
Condition(s):Anemia in End-Stage Renal DiseaseLast Updated:December 18, 2019Completed
Condition(s):Heart; Dysfunction Postoperative, Cardiac Surgery; Anemia, Iron-DeficiencyLast Updated:April 5, 2017Terminated
Condition(s):Encephalopathy; Erythropoietin; Newborn AsphyxiaLast Updated:March 19, 2024Recruiting
Condition(s):Anemia of End Stage Renal DiseaseLast Updated:September 13, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.